Long-term efficacy and safety outcomes with OROS-MPH in adults with ADHD

Methylphenidate (MPH) is widely prescribed for adults with attention deficit hyperactivity disorder (ADHD), but data on long-term treatment and maintenance of effect are lacking. Osmotic release oral system-methylphenidate (OROS–MPH) was evaluated in a 52-wk open-label study in subjects who had prev...

Descripción completa

Detalles Bibliográficos
Autores principales: Buitelaar, Jan K., Trott, Götz-Erik, Hofecker, Maria, Waechter, Sandra, Berwaerts, Joris, Dejonkheere, Joachim, Schäuble, Barbara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2012
Materias:
Thematic Section: Attention-Deficit Hyperactivity Disorder (ADHD)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3243903/
https://www.ncbi.nlm.nih.gov/pubmed/21798108
http://dx.doi.org/10.1017/S1461145711001131

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3243903/
https://www.ncbi.nlm.nih.gov/pubmed/21798108
http://dx.doi.org/10.1017/S1461145711001131

Ejemplares similares